CareTrust REIT Inc. Common Stock (CTRE)

FairStock Score: 72/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

CareTrust owns skilled nursing and seniors housing and net-leases them to operators. That can be a durable income stream, but the moat is modest: long leases and operator relationships help, yet reimbursement and operator credit drive results. The filed figures show strong profit growth. In fiscal Q2 2026, the quarter ended 2026-06-30, net income was $89.0M and diluted EPS was $0.38, versus $68.5M and $0.35 in fiscal Q2 2025. For fiscal 2025, the year ended 2025-12-31, net income was $320.5M and diluted EPS $1.57, up from $125.1M and $0.80 in fiscal 2024. But the revenue lines are strange: fiscal Q3 2025, ended 2025-09-30, shows revenue of $132.4M, while fiscal Q2 2026 is filed at only $4.6M and fiscal 2025 at $1.2M. For a REIT, FFO and AFFO are the right measures, and they are not in the data. At the 2026-10-13 close of $36.56, FairStock shows P/B 1.92, P/E 22.85, dividend yield 4.16%, D/E 0.27, ROCE 4.44%, FCF yield 5.0%, Altman Z 3.62, and a weak Piotroski F-score of 4/9. FairStock calls it a TURNAROUND because it returned to profit after a loss within three years. Leverage is modest, but the valuation is not obviously cheap and the top line needs clarification. I see a fair-priced healthcare landlord with real income growth and limited cushion.

In plain English: CareTrust owns skilled nursing and seniors housing buildings and leases them to healthcare operators. Its profits have climbed and its debt load looks modest, with a solid dividend, but the reported revenue figures are inconsistent and the shares do not look especially cheap on the numbers. Without the cash-flow measures that matter most for property owners, the stock looks closer to fair than to a bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer